Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 13, 2005. The report serves as a notification of transactions involving directors, persons discharging managerial responsibility, or connected persons regarding the company's ordinary shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The material change reported is a transfer of 12,536 Ordinary Shares from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991. This transaction occurred on October 12, 2005, and was advised to the company on October 13, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust for current and former employees, and that three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the trust shares similarly to other employees.
Key Facts for Investor Verification
- Transaction Type: Transfer of shares from the GSK Trust to employee plan participants.
- Share Volume: 12,536 Ordinary Shares.
- Directors Involved: Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop are noted as having interests in the trust.
- Regulatory Basis: Notification made under Disclosure Rule 3.1.4R(1)(b).
- Financial Data: No financial metrics are included in this specific filing.